doxifluridine has been researched along with Nasopharyngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KP; Chang, YS; Chen, LC; Hao, SP; Hsueh, C; Liang, Y; Tsang, NM; Yu, JS | 1 |
| Chang, YS; Chen, CC; Chen, LC; Liang, Y; Tsang, NM | 1 |
2 other study(ies) available for doxifluridine and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Pharmacological; Biomarkers, Tumor; Carcinoma; Cytoplasm; Drug Resistance, Neoplasm; Female; Floxuridine; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Prognosis; Survival Analysis; Thymidine Phosphorylase | 2008 |
Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
Topics: Antimetabolites, Antineoplastic; Carcinoma; Cell Line, Tumor; Floxuridine; Humans; Nasopharyngeal Neoplasms; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Structure, Tertiary; Signal Transduction; Thymidine Phosphorylase; Viral Matrix Proteins | 2010 |